Use of palliative sedation following Medical Assistance in Dying (MAiD) legislation: A mixed-methods study of palliative care providers.

Canada End-of-life care Medical Assistance in Dying Palliative care Palliative sedation

Journal

Palliative & supportive care
ISSN: 1478-9523
Titre abrégé: Palliat Support Care
Pays: England
ID NLM: 101232529

Informations de publication

Date de publication:
08 2023
Historique:
medline: 21 7 2023
pubmed: 27 6 2023
entrez: 27 6 2023
Statut: ppublish

Résumé

Palliative sedation (PS) and Medical Assistance in Dying (MAiD) are options for end-of-life (EOL) care in Canada, since the latter was legalized in 2016. Little research to date has explored the potential impact of MAiD on PS practices. This study investigated physicians' perceptions of their practices surrounding PS and how they may have changed since 2016. A survey ( Thematic analysis yielded the following themes: (1) Increased patient/family knowledge of EOL care; (2) More frequent/fulsome discussions; (3) Normalization/repositioning of PS; and (4) Conflation and differentiation of PS/MAiD. Across these themes, participants espoused increased patient, family, and provider comfort with PS, which may stem equally from the advent of MAiD and the growth of palliative care in general. Participants also emphasized that, following MAiD, PS is viewed as a less radical intervention. This is the first study to investigate physicians' perspectives on the impact of MAiD on PS. Participants strongly opposed treating MAiD and PS as direct equivalents, given the differences in intent and eligibility. Participants stressed that MAiD requests/inquiries should prompt individualized assessments exploring all avenues of symptom management - the results of which may or may not include PS.

Identifiants

pubmed: 37365818
doi: 10.1017/S1478951523000706
pii: S1478951523000706
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

570-577

Auteurs

Anneliese Mills (A)

Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada.
Department of Family and Community Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

Amy Nolen (A)

Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada.
Division of Palliative Care, Sunnybrook Health Sciences Centre, Toronto, Toronto, Toronto.

Fahad Qureshi (F)

Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada.
Department of Family and Community Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

Debbie Selby (D)

Division of Palliative Care, Sunnybrook Health Sciences Centre, Toronto, Toronto, Toronto.
Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH